Analytica chimica acta · 2026
ATP-responsive NIR-Ⅱ fluorescence/mass spectrometry dual-modal nanoprobe for precision diagnosis of metabolic dysfunction-associated steatohepatitis.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Huang Fei, Jing Quan, Wang Ningli, Pei Dong, Zhang Jinlong, Hai Jun, Liu Can
Аннотация
BACKGROUND: Metabolic dysfunction-associated steatohepatitis (MASH) requires analytical tools capable of noninvasive and dynamic evaluation of hepatic metabolic dysfunction in vivo. Adenosine triphosphate (ATP) is a key indicator of mitochondrial activity and energy metabolism, yet its selective detection in complex biological environments remains challenging.
RESULTS: An ATP-responsive dual-modal nanoplatform, NA1060@ZIF-90, was developed by integrating near-infrared Ⅱ (NIR-Ⅱ) fluorescence imaging with mass spectrometry imaging (MSI). ATP-Zn2+ coordination induces disassembly of the ZIF-90 framework, activating a turn-on NIR-Ⅱ fluorescence signal and enabling sensitive and selective ATP detection. The platform allows real-time visualization of hepatic ATP depletion and recovery in free-fatty-acid (FFA) treated hepatocytes and a methionine-choline-deficient (MCD) diet-induced MASH mouse model. MSI analysis further provides spatial molecular validation by correlating probe activation with lipid metabolic remodeling.
SIGNIFICANCE: This work presents an analytical strategy that couples dynamic in vivo metabolic imaging with label-free spatial molecular analysis, offering a robust framework for MASH diagnosis, disease evaluation, and therapeutic efficacy assessment, and highlighting the potential of ATP-responsive nanomaterials in metabolic disease analysis.
RESULTS: An ATP-responsive dual-modal nanoplatform, NA1060@ZIF-90, was developed by integrating near-infrared Ⅱ (NIR-Ⅱ) fluorescence imaging with mass spectrometry imaging (MSI). ATP-Zn2+ coordination induces disassembly of the ZIF-90 framework, activating a turn-on NIR-Ⅱ fluorescence signal and enabling sensitive and selective ATP detection. The platform allows real-time visualization of hepatic ATP depletion and recovery in free-fatty-acid (FFA) treated hepatocytes and a methionine-choline-deficient (MCD) diet-induced MASH mouse model. MSI analysis further provides spatial molecular validation by correlating probe activation with lipid metabolic remodeling.
SIGNIFICANCE: This work presents an analytical strategy that couples dynamic in vivo metabolic imaging with label-free spatial molecular analysis, offering a robust framework for MASH diagnosis, disease evaluation, and therapeutic efficacy assessment, and highlighting the potential of ATP-responsive nanomaterials in metabolic disease analysis.